Helius Medical announces 1-for-15 reverse stock split

Helius Medical (HSDT) Technologies announced a 1-for-15 reverse split of its Class A common stock, par value $0.001, effective at 5:00 pm Eastern time on May 1, 2025. Beginning on May 2, 2025, the Company’s common stock will trade on The Nasdaq Capital Market on a split adjusted basis. At the Company’s annual meeting of stockholders on April 21, 2025, the stockholders approved a proposal to amend the Company’s Certificate of Incorporation to effect a reverse split of the Company’s outstanding common stock at a ratio in the range of 1-for-2 to 1-for-30 to be determined at the discretion of our Board of Directors, whereby each outstanding 2 to 30 shares would be combined, converted and changed into 1 share of common stock, to enable the Company to comply with the Nasdaq Stock Market’s continued listing requirements. Subsequently, the Board of Directors approved the reverse split at a ratio of 1-for-15. As a result of the reverse stock split, every 15 shares of the company’s common stock issued and outstanding will be automatically converted into one share of common stock, with no change in the $0.001 par value per share or authorized number of shares of common stock.